These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11137556)

  • 1. Best supportive care for the anaemia of myelodysplasia: inclusion of recombinant erythropoietin therapy?
    Bowen DT; Hellstrom-Lindberg E
    Leuk Res; 2001 Jan; 25(1):19-21. PubMed ID: 11137556
    [No Abstract]   [Full Text] [Related]  

  • 2. Recombinant human erythropoietin in patients with myelodysplastic syndrome and myelofibrosis.
    Mohr B; Herrmann R; Huhn D
    Acta Haematol; 1993; 90(2):65-70. PubMed ID: 8285020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Transfusional independence in a patient with refractory anemia with excess blasts-2 refractory to 5-azacitidine treated with deferasirox and colony stimulating factors].
    Moreno de Gusmão B; Guinea de Castro JM; Perez-Persona E; Oiartzabal I
    Med Clin (Barc); 2014 Jan; 142(2):91-2. PubMed ID: 23790532
    [No Abstract]   [Full Text] [Related]  

  • 4. Recombinant erythropoietin for refractory anemia with ring sideroblasts.
    Musto P; Catalano L; Andriani A; Bodenizza C; Cascavilla N; Di Renzo N; Melillo L; Cicoira L; Carotenuto M; Rotoli B
    Haematologica; 1992; 77(2):185-6. PubMed ID: 1398306
    [No Abstract]   [Full Text] [Related]  

  • 5. Recombinant human erythropoietin (rHuEPO) for treatment of myelodysplastic syndrome.
    Zeigler ZR; Jones D; Rosenfeld CS; Shadduck RK
    Stem Cells; 1993 Jan; 11(1):49-55. PubMed ID: 8457781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoietin: can we afford to use it? Can we afford not to?
    Laird J
    Transfus Med; 2006 Jun; 16(3):204-5. PubMed ID: 16764600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin and transfusions among critically ill patients.
    Bagshaw SM; Ghali WA
    JAMA; 2003 Mar; 289(12):1511; author reply 1512. PubMed ID: 12672766
    [No Abstract]   [Full Text] [Related]  

  • 8. Prolonged administration of erythropoietin increases erythroid response rate in myelodysplastic syndromes: a phase II trial in 281 patients.
    Terpos E; Mougiou A; Kouraklis A; Chatzivassili A; Michalis E; Giannakoulas N; Manioudaki E; Lazaridou A; Bakaloudi V; Protopappa M; Liapi D; Grouzi E; Parharidou A; Symeonidis A; Kokkini G; Laoutaris NP; Vaipoulos G; Anagnostopoulos NI; Christakis JI; Meletis J; Bourantas KL; Zoumbos NC; Yataganas X; Viniou NA;
    Br J Haematol; 2002 Jul; 118(1):174-80. PubMed ID: 12100145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thalidomide abolishes transfusion-dependence in selected patients with myelodysplastic syndromes.
    Musto P; Falcone A; Sanpaolo G; Bisceglia M; Matera R; Carella AM
    Haematologica; 2002 Aug; 87(8):884-6. PubMed ID: 12161367
    [No Abstract]   [Full Text] [Related]  

  • 10. The clinical utility of epoetin in cancer patients: a matter of perspective.
    Barosi G; Marchetti M
    Haematologica; 2000 May; 85(5):449-50. PubMed ID: 10800156
    [No Abstract]   [Full Text] [Related]  

  • 11. High doses of intravenous recombinant erythropoietin for the treatment of anaemia in myelodysplastic syndrome.
    Goy A; Belanger C; Casadevall N; Picard F; Guesnu M; Jaulmes D; Poisson D; Varet B
    Br J Haematol; 1993 Jun; 84(2):232-7. PubMed ID: 8398823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A validated decision model for treating the anaemia of myelodysplastic syndromes with erythropoietin + granulocyte colony-stimulating factor: significant effects on quality of life.
    Hellström-Lindberg E; Gulbrandsen N; Lindberg G; Ahlgren T; Dahl IM; Dybedal I; Grimfors G; Hesse-Sundin E; Hjorth M; Kanter-Lewensohn L; Linder O; Luthman M; Löfvenberg E; Oberg G; Porwit-MacDonald A; Rådlund A; Samuelsson J; Tangen JM; Winquist I; Wisloff F;
    Br J Haematol; 2003 Mar; 120(6):1037-46. PubMed ID: 12648074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The treatment of anaemia in the myelodysplastic syndromes with recombinant human erythropoietin.
    Bowen D; Culligan D; Jacobs A
    Br J Haematol; 1991 Mar; 77(3):419-23. PubMed ID: 2012769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of a patient with myelodysplastic syndrome (RAEB) with Darbepoetin-alfa in combination with Pegfilgrastim.
    Jakob A; Hirsch FW; Engelhardt M
    Ann Hematol; 2005 Oct; 84(10):694-5. PubMed ID: 15931534
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cyclosporine A based therapy for myelodysplastic syndrome].
    Li ZL; Gong M; Xu SH; Huang FZ; Chen YR; Ma YG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):867-70. PubMed ID: 16277860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The health(y) cost of erythropoietin in orthopedic surgery.
    Fergusson DA; Hébert P
    Can J Anaesth; 2005 Apr; 52(4):347-51. PubMed ID: 15814746
    [No Abstract]   [Full Text] [Related]  

  • 17. Donor lymphocyte infusions for post-transplant relapse of refractory anemia with excess blasts and monosomy 7.
    Skinner R; Velangi M; Bown N
    Pediatr Blood Cancer; 2008 Mar; 50(3):670-2. PubMed ID: 17253642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with erythropoietin after allogeneic bone marrow transplantation: a randomized, double-blind study.
    Klaesson S; Ringdén O; Ljungman P; Lönnqvist B; Wennberg L
    Transplant Proc; 1994 Jun; 26(3):1827-8. PubMed ID: 8030158
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of erythropoietin-stimulating agents versus supportive care in newborns with hereditary spherocytosis: a single centre's experience.
    Morrison JF; Neufeld EJ; Grace RF
    Eur J Haematol; 2014 Aug; 93(2):161-4. PubMed ID: 24660843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up of myelodysplastic syndrome patients with moderate/severe anaemia receiving human recombinant erythropoietin + 13-cis-retinoic acid and dihydroxylated vitamin D3: independent positive impact of erythroid response on survival.
    Crisà E; Foli C; Passera R; Darbesio A; Garvey KB; Boccadoro M; Ferrero D
    Br J Haematol; 2012 Jul; 158(1):99-107. PubMed ID: 22571649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.